Get started
Author

Gülhan Dinç

Observed names: Gulhan Dinc, Gulhan Dinç, Gülhan Dinç, Gülhan Dinc
ORCID: 0009-0007-6025-7800
Observed ORCID: 0009-0007-6025-7800
OpenAlex ID: A5101385876
Prognostic Value of Inflammation and Nutrition-Based Scores in Non-Small Cell Lung Cancer
2023 · Mert Erciyestepe, Oğuzhan Selvi, et al. · Medical Principles and Practice · 12
The effect of concomitant proton pump inhibitor use on survival outcomes of Nivolumab-treated renal cell carcinoma patients: a multicenter study
2023 · Muzaffer Uğraklı, Mehmet Zahid Koçak, et al. · Journal of Cancer Research and Clinical Oncology · 4
PDF
Comparison of clinical and prognostic characteristics of patients with classic and AIDS-related Kaposi sarcoma: A single-center experience
2025 · Okan Aydin, Mert Erciyestepe, et al. · Medicine · 3
Factors Affecting Recurrence and Survival in Stage IIA Colon Cancer Patients
2024 · Mert Erciyestepe, Oğuzhan Selvi, et al. · Oncology · 3
The relationship between body mass index and survival in patients with renal cell carcinoma treated with nivolumab
2025 · Rumeysa Çolak, İlkay Gültürk, et al. · Journal of Chemotherapy · 2
The Impact of Concurrent Proton Pump Inhibitors on Nivolumab Response in Metastatic Non-Small Cell Lung Cancer: A Multicenter Real-Life Study
2026 · Engin Hendem, Mehmet Zahid Koçak, et al. · Medicina · 1
PDF
Author Correction: The prognostic impact of Her2 status in early triple negative breast cancer: a Turkish Oncology Group (TOG) study
2025 · Neslihan Özyurt, Ali Alkan, et al. · Scientific Reports · 1
Sorafenib vs chemotherapy in the treatment of locally advanced or metastatic, radioactive iodine-refractory differentiated thyroid cancer: real-world data from Turkey
2024 · Nargiz Majidova, Shahla Aghamaliyeva, et al. · Journal of Chemotherapy · 1
The prognostic impact of Her2 status in early triple negative breast cancer: a Turkish Oncology Group (TOG) study
2024 · Neslihan Özyurt, Ali Alkan, et al. · Scientific Reports · 1
Which factors help to determine the long-term response to first-line tyrosine kinase inhibitors in patients with metastatic renal cell carcinoma: A Turkish multi-centre study
2024 · Nargiz Majidova, Mustafa Seyyar, et al. · Biomolecules and Biomedicine · 1
Prognostic Value of the Modified Glasgow Prognostic Score in Patients with Metastatic Renal Cell Carcinoma Receiving Nivolumab as Second-Line Therapy: A Multicentre Retrospective Cohort Study
2026 · Sedat Biter, Ertuğrul Bayram, et al. · Medicina
Dementia as a rare neurological adverse event of Nivolumab in a patient with metastatic renal cell carcinoma
2026 · Gulhan Dinc · Journal of Oncology Pharmacy Practice
Prognostic Significance of the CPS-EG Score in Triple-Negative Breast Cancer Treated with Neoadjuvant Chemotherapy
2026 · Neslihan Özyurt, Ali Alkan, et al. · Cancers
PDF
Clinicopathological Characteristics of Patients with HR-Positive/HER2-Negative Metastatic Breast Cancer Experiencing Early Progression Within 6 Months of CDK4/6 Inhibitor Therapy
2026 · Okan Aydın, Gülhan Dinç, et al. · Eurasian Journal of Medical Investigation
Predictors of Recurrence Following Curative-Intent Local Therapy for Oligometastatic Renal Cell Carcinoma: A Multicenter Retrospective Cohort Study from the Turkish Oncology Group (TOG)
2026 · Engin Hendem, Gülhan Dinç, et al. · Eurasian Journal of Medical Investigation
Analysis of the impact of IMDC score parameters on patients with metastatic clear cell renal cell carcinoma
2025 · Mert Erciyestepe, Tugce Kubra Gunes, et al. · Biomarkers in Medicine
Kanserde Takip
2025 · Şermin Dinç Sonuşen, İbrahim Bilen, et al. · Akademisyen Kitabevi eBooks
PDF
Identifying Preventable Causes of Worsening Heart Failure: A Single-Center Retrospective Analysis
2025 · Gulhan Dinç, Fatih Borlu, et al. · DAHUDER Medical Journal
PDF
The Efficiency of Concomitant Antibiotic Usage On Survival Outcomes of Nivolumab-Treated Metastatic Renal Cell Carcinoma Patients: A Multicenter Experience
2025 · Muzaffer Uğraklı, Mehmet Zahid Koçak, et al. · Research Square
Prognostic value of systemic inflammatory markers in renal cell carcinoma with isolated lung metastases: A retrospective analysis
2024 · Nargiz Majidova, Ali Kaan Güren, et al. · Turkish Journal of Clinics and Laboratory
PDF
Kanser Hastalarının Başvurduğu Geleneksel ve Tamamlayıcı Tedaviler - Tıbbi Onkolog Gözü ile Bakış ve Onkolojik İlaçlarla Etkileşim
2024 · Ayşegül Sakin, Kubilay Karaboyun, et al. · Akademisyen Kitabevi eBooks
PDF
Isırgan Otu (Urtica Dioica)
2024 · Gülhan Dinç · Akademisyen Kitabevi eBooks
Works count: 22
Citation count: 29
H-index: 3
I10-index: 1
Year
Topic
Type